Hormone and antihormone withdrawal: implications for the management of androgen-independent prostate cancer
Open Access
- 1 January 1996
- Vol. 47 (1) , 61-69
- https://doi.org/10.1016/s0090-4295(96)80011-2
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Mutation of the Androgen-Receptor Gene in Metastatic Androgen-Independent Prostate CancerNew England Journal of Medicine, 1995
- Hormone-induced dissociation of the androgen receptor-heat-shock protein complex: use of a new monoclonal antibody to distinguish transformed from nontransformed receptorsBiochemistry, 1992
- The human androgen receptor: Structure/function relationship in normal and pathological situationsThe Journal of Steroid Biochemistry and Molecular Biology, 1992
- The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogensThe Journal of Steroid Biochemistry and Molecular Biology, 1992
- Anti-androgens and the mutated androgen receptor of LNCaP cells: differential effects on binding affinity, heat-shock protein interaction, and transcription activationBiochemistry, 1992
- A mutation in the ligand binding domain of the androgen receptor of human INCaP cells affects steroid binding characteristics and response to anti-androgensBiochemical and Biophysical Research Communications, 1990
- Regulation of growth and epidermal growth factor receptor levels of LNCaP prostate tumor cells by different steroidsInternational Journal of Cancer, 1988
- Effects of flutamide and aminoglutethimide on plasma 5α-reduced steroid glucuronide concentrations in castrated patients with cancer of the prostateThe Journal of Steroid Biochemistry and Molecular Biology, 1987
- A wide range of sensitivities to androgens develops in cloned shionogi mouse mammary tumor cellsThe Prostate, 1986
- Adrenal androgen blockade in relapsed prostate cancerEuropean Journal of Cancer and Clinical Oncology, 1985